X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adolescent (2) 2
adult (2) 2
adults (2) 2
anti-retroviral agents - administration & dosage (2) 2
child (2) 2
child, preschool (2) 2
efavirenz (2) 2
female (2) 2
humans (2) 2
index medicus (2) 2
male (2) 2
raltegravir potassium - administration & dosage (2) 2
risk (2) 2
young adult (2) 2
abacavir (1) 1
adolescence (1) 1
adolescents (1) 1
africa - epidemiology (1) 1
africa south of the sahara (1) 1
aged (1) 1
aids/hiv (1) 1
amplification (1) 1
anti-hiv agents - administration & dosage (1) 1
anti-infective agents - administration & dosage (1) 1
antiretroviral agents (1) 1
antiretroviral drugs (1) 1
antiretroviral therapy (1) 1
arachis (1) 1
association (1) 1
biology and life sciences (1) 1
biomarkers (1) 1
body mass index (1) 1
body weight (1) 1
cd4 antigen (1) 1
children (1) 1
clinical trials (1) 1
councils (1) 1
diet therapy - methods (1) 1
disease control (1) 1
disease progression (1) 1
drug administration schedule (1) 1
drug therapy (1) 1
follow-up studies (1) 1
food and nutrition (1) 1
funding (1) 1
genotypes (1) 1
health aspects (1) 1
health services accessibility - trends (1) 1
highly active antiretroviral therapy (1) 1
hiv (1) 1
hiv infection (1) 1
hiv infections - diagnostic imaging (1) 1
hiv infections - drug therapy (1) 1
hiv infections - epidemiology (1) 1
hiv infections - mortality (1) 1
hiv infections - therapy (1) 1
hiv patients (1) 1
hiv/aids (1) 1
human immunodeficiency virus (1) 1
human immunodeficiency virus--hiv (1) 1
immune reconstitution (1) 1
immune-activation (1) 1
immunodeficiency (1) 1
immunology (1) 1
infection (1) 1
infections (1) 1
infectious diseases (1) 1
inflammation (1) 1
inhibitors (1) 1
insecurity (1) 1
integrase (1) 1
kenya - epidemiology (1) 1
malawi - epidemiology (1) 1
medical research (1) 1
medicine (1) 1
medicine and health sciences (1) 1
medicine, general & internal (1) 1
micronutrients - administration & dosage (1) 1
middle aged (1) 1
morbidity (1) 1
mortality (1) 1
motivation (1) 1
mutation (1) 1
natural foods (1) 1
non-nucleoside reverse transcriptase inhibitors (1) 1
nucleoside reverse transcriptase inhibitors (1) 1
nucleosides (1) 1
outcomes (1) 1
raltegravir (1) 1
randomization (1) 1
research and analysis methods (1) 1
restoration (1) 1
rna-directed dna polymerase (1) 1
south-africa (1) 1
supervision (1) 1
survival analysis (1) 1
tenofovir (1) 1
testing (1) 1
therapy (1) 1
treatment outcome (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS medicine, ISSN 1549-1676, 12/2018, Volume 15, Issue 12, p. e1002706
Background In sub-Saharan Africa, individuals infected with HIV who are severely immunocompromised have high mortality (about 10%) shortly after starting... 
MORTALITY | BIOMARKERS | SOUTH-AFRICA | MEDICINE, GENERAL & INTERNAL | IMMUNE RECONSTITUTION | EFAVIRENZ | ADULTS | INFECTION | RESTORATION | IMMUNODEFICIENCY | CHILDREN | HIV Infections - diagnostic imaging | Africa - epidemiology | Zimbabwe - epidemiology | Drug Administration Schedule | Follow-Up Studies | Kenya - epidemiology | HIV Infections - epidemiology | Humans | Raltegravir Potassium - administration & dosage | Child, Preschool | Malawi - epidemiology | Uganda - epidemiology | Male | Disease Progression | Anti-HIV Agents - administration & dosage | Young Adult | Anti-Retroviral Agents - administration & dosage | Adolescent | Adult | Female | HIV Infections - drug therapy | Child | Health Services Accessibility - trends | Drug therapy | HIV infection | Raltegravir | Testing | Adolescence | Therapy | RNA-directed DNA polymerase | Viremia | Funding | Clinical trials | Risk | Viruses | Infections | Tenofovir | Randomization | Motivation | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Children | Adolescents | Genotypes | Supervision | University colleges | Integrase | Antiretroviral drugs | Medical research | Mortality | Immune reconstitution | Inflammation | Disease control | Antiretroviral therapy | Morbidity | CD4 antigen | Medicine | Amplification | Non-nucleoside reverse transcriptase inhibitors | Inhibitors | Councils | Abacavir | Nucleosides | Biomarkers | Mutation | HIV | Human immunodeficiency virus
Journal Article
by Mallewa, Jane and Szubert, Alexander J and Mugyenyi, Peter and Chidziva, Ennie and Thomason, Margaret J and Chepkorir, Priscilla and Abongomera, George and Baleeta, Keith and Etyang, Anthony and Etyang, Timothy and Warambwa, Colin and Melly, Betty and Mudzingwa, Shepherd and Kelly, Christine and Agutu, Clara and Wilkes, Helen and Nkomani, Sanele and Musiime, Victor and Musiime, Alex and Lugemwa, Abbas and Pett, Sarah L and Bwakura-Dangarembizi, Mutsa and Prendergast, Andrew J and Gibb, Diana M and Walker, Ann Sarah and Walker, A Sarah and Berkley, Jay and Berkley, James A and Kityo, Cissy and Wavamunno, Priscilla and Nambi, Esther and Ocitti, Paul and Ndigendawani, Milly and Kabahenda, Sheila and Kemigisa, Mable and Acen, Juliet and Olebo, David Francis and Mpamize, Gordon and Amone, Geoffrey and Amone, Alex and Okweny, David and Mbonye, Andrew and Nambaziira, Florence and Rweyora, Angela and Kangah, Mary and Kabaswahili, Beatrice and Abach, James and Omongin, Joseph and Aciro, Irene and Philliam, Aleti and Arach, Beatrice and Ocung, Emmanuel and Miles, Peter and Adong, Claudia and Tumsuiime, Constance and Kidega, Patrick and Otto, Ben and Apio, Florence and Mukuye, Andrew and Abwola, Mary and Ssennono, Fred and Baliruno, David and Tuhirwe, Stephen and Namisi, Ronald and Kigongo, Fredrick and Kikyonkyo, Dickson and Mushahara, Furaha and Tusiime, Julian and Nankya, Agnes and Atwongyeire, Dickens and Sirikye, Sowal and Myalo, Sula and Noowe, Nelson and Kasozi, Mariam and Mwebe, Sandra and Atwine, Lorna and Senkindu, Tapson and Natuhurira, Ian and Katemba, Chrispus and Ninsiima, Emily and Acaku, Moses and Kyomuhangi, Joy and Ankunda, Rogers and Tukwasibwe, Deogratious and Ayesiga, Lillian and Hakim, James and Nathoo, Kusum and Reid, Andrew and Mhute, Tawand and Tinago, Gloria and Bhiri, Joyline and Phiri, Misheck and Steamer, John and Nhema, Ruth and Musoro, Godfrey and Mutsai, Shirley and Nemasango, Beauty and Moyo, Columbus and Chitongo, Stuart and Rashirai, Kennias and ... and REALITY Trial Team and REALITY trial team
The Lancet HIV, ISSN 2352-3018, 05/2018, Volume 5, Issue 5, pp. e231 - e240
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.